Skip to content

Lipegfilgrastim

Lonquex (lipegfilgrastim) is a protein pharmaceutical. Lipegfilgrastim was first approved as Lonquex on 2013-07-25. It has been approved in Europe to treat neutropenia.
Trade Name Lonquex
Common Name Lipegfilgrastim
Indication neutropenia
Drug Class Pegylated compounds; colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF)
Lipegfilgrastim
Get full access now